Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. - sprookjes - yvandenbroek - TriplyDB

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

http://www.wikidata.org/entity/Q34239936

about

Essential regulation of lung surfactant homeostasis by the orphan G protein-coupled receptor GPR116 Pivotal roles of GM-CSF in autoimmunity and inflammation Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications A New Scale to Assess the Severity and Prognosis of Pulmonary Alveolar Proteinosis Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis Autoimmune pulmonary proteinosis in a Chilean teenager, a rare aetiology of interstitial lung disease.Autoimmunity as a predisposition for infectious diseases The molecular basis of pulmonary alveolar proteinosis Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.Autoimmune pulmonary alveolar proteinosis co-existing with breast cancer: a case report.Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis.Continuous positive airway pressure ventilation during whole lung lavage for treatment of alveolar proteinosis -A case report and review of literature.A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry.Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.Protein microarrays: a new tool for the study of autoantibodies in immunodeficiency Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis.Protein microarrays identify disease-specific anti-cytokine autoantibody profiles in the landscape of immunodeficiency.Post-infectious inflammatory response syndrome (PIIRS): Dissociation of T-cell-macrophage signaling in previously healthy individuals with cryptococcal fungal meningoencephalitis.Characterization of pathogenic human monoclonal autoantibodies against GM-CSF.The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis.Therapy options in pulmonary alveolar proteinosis.Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges.Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013.A cell free assay system estimating the neutralizing capacity of GM-CSF antibody using recombinant soluble GM-CSF receptor Pulmonary alveolar proteinosis: time to shift?Targeting GM-CSF in inflammatory diseases.Accelerating Scientific Advancement for Pediatric Rare Lung Disease Research. Report from a National Institutes of Health-NHLBI Workshop, September 3 and 4, 2015.Pulmonary Alveolar Proteinosis Syndrome.Targeting cholesterol homeostasis in lung diseases.A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosis.Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome.GM-CSF as a therapeutic target in autoimmune diseases.Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis

P2860

Q24293168-31351EBF-6007-4DED-B024-EBB5A8E0F0B1 Q26830824-76F87022-3A99-47F7-9918-C7DC09B0A71E Q27681863-9B4D803B-0B82-489F-BCA0-FD49DE25DA87 Q28388126-F873561C-40E9-43C2-A0AC-951749B269CC Q33648016-BFB11178-4C5C-4AE1-A2B6-6758FECF9896 Q33691075-C76CD233-F279-48FB-AB5D-3D2EBDED0E14 Q33747588-55E5B575-6C40-49B5-9066-570B75C09B04 Q33835843-E70DB4A1-ABC6-490C-8DF0-7814687A5094 Q33988125-2E77B87B-A422-43F2-9935-7DEC8CF05342 Q34073404-8F7F2B86-BD95-48C9-A43C-20FA6F1C1B2D Q34402453-8322C151-6D43-4406-8BBD-2F3CA2FF7CFB Q34491280-2AF975D4-9856-4875-948C-3A7F118BF836 Q34650719-E68D3207-FF55-4F87-AB98-F1BDF6517F7D Q34992980-10525A6A-07F8-4DAA-9698-69B9073096E1 Q35006216-2395E33D-AA4E-47D4-848C-2EB8D6C239DE Q35078403-DC9F127F-9806-42DE-810F-389A3203C3A8 Q35197274-EEAAA0A9-AF52-4613-A662-D087E863EE63 Q35296572-8DA92863-09FE-442B-B51E-BC81DD54CAAE Q35743143-084775D2-9504-45B5-A415-053A858FD0BF Q35768564-FAA2D1B7-D072-4CE1-94F2-FC4FBD344FA1 Q36470632-870B4040-1748-4A62-830E-9DADDE431AE9 Q36781260-621052BF-A8CF-441E-A0F2-71B6684ECCEF Q36835759-B6100B4A-9CBC-4447-8925-67B13102AA44 Q37362027-CC555C62-1C4F-4A68-82C7-4590449FBDB6 Q37418292-520B1B8F-5437-4788-9365-E68B7E762D76 Q37698322-81A2CB29-EA63-4E01-A292-6C31F762173B Q37774483-80FBC173-6946-4F8B-B77F-B1481D94F5F9 Q38041659-125E030E-AB08-46EB-847F-E9144DCCA0D8 Q38049370-F595E3C1-D9DB-479D-AF59-F29F8F55C172 Q38333731-74A39B58-AD57-4348-8460-A38447046521 Q38416755-4015393F-CE1C-4F32-8E45-15892445C8C2 Q38657999-8C3D3384-6160-468B-917E-44BD504DD8AA Q38786177-4F229401-F5F8-471F-9A57-14686E2C9A02 Q38924994-04565097-234B-40B2-89C7-57312F9C3040 Q41581562-1F234A8C-4A3A-4E27-9C23-AF60FFC2B26F Q41958540-FB1E76B2-461A-4978-A24C-3343452C78D0 Q42852347-3B9802B4-C8B2-4383-A843-92727D28E529 Q47138480-FF60F65A-B9CD-44AE-B801-0728BB8D1E97 Q51136551-AE2C872F-4875-4019-9182-4B107ADE388E Q58797780-FB04EC74-21B4-4FE6-BEF6-BB2E98D98CDB

P2860

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

http://www.wikidata.org/entity/Q34239936

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@ast

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@en

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@nl

type

label

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@ast

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@en

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@nl

prefLabel

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@ast

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@en

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@nl

P1433

Q34239936-082A577B-EB3D-44B1-B51D-F21C4F79ACAC

P1476

Q34239936-354D6188-8AB7-46B1-A7D8-F737E2CB7CFD

P2093

Q34239936-2DB8C820-38B3-413F-98C3-BD741FA8F815

Q34239936-4D9D7015-C9AB-40CA-A78E-3A02470044B7

Q34239936-53C002B2-8101-44EF-824E-8323C5BA2778

Q34239936-72B7DB3F-C430-491C-A14E-EF543D46A94C

Q34239936-BD5ACDAB-FAE1-4E30-AAC8-7B5CD8B3B44E

Q34239936-D2434C75-EBF9-4658-ACB3-FB02EA0836FF

Q34239936-D6DA6B36-6A54-4FF5-B75C-130CA892783A

Q34239936-F8226B81-D61E-4889-9324-395608A9FC35

Q34239936-F8DF4673-F9F1-415B-8DB5-630A9434DB17

P2860

Q34239936-22417686-E576-4E42-9840-D29CC2A01A34

Q34239936-6F6FB905-2F59-44A3-A5B8-0971F55D0C22

Q34239936-909FE0A3-33BF-4F65-A9F7-72F7EC34FAF8

P304

Q34239936-3C8182EC-1EF1-4D05-9992-647B46393124

P31

Q34239936-599396E8-2EC4-4684-B3AD-AB47B6549511

P356

Q34239936-E675454C-1ACE-427B-A3B5-E99CEB1030BA

P407

Q34239936-179C920A-B270-4C91-9DFA-5B143483AE93

P433

Q34239936-48474EC7-FC23-4304-8011-5F90070F0B04

P478

Q34239936-8468976E-1C0B-418E-94D8-75E3F9589137

P577

Q34239936-290170A6-110B-43D6-9A72-AE3DA36CDCE2

P698

Q34239936-B5877C14-F354-473E-A3D7-5994BFDD1CA0

P921

Q34239936-59598097-F9FC-468B-81CE-0D01ECECF3C3

P932

Q34239936-2BDFB2BC-A2C8-427B-AEA5-E10192AF010C

P356

P1433

The New England Journal of Medicine

P1476

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

@en

P2093

Brenna C Carey

http://www.w3.org/2001/XMLSchema#string

Bruce C Trapnell

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Whitsett

http://www.w3.org/2001/XMLSchema#string

Kanji Uchida

http://www.w3.org/2001/XMLSchema#string

Maurizio Luisetti

http://www.w3.org/2001/XMLSchema#string

Robert E Wood

http://www.w3.org/2001/XMLSchema#string

Susan E Wert

http://www.w3.org/2001/XMLSchema#string

Takuji Suzuki

http://www.w3.org/2001/XMLSchema#string

Takuro Sakagami

http://www.w3.org/2001/XMLSchema#string

P2860

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.

Pulmonary Alveolar Proteinosis

P304

2679-2681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMC0904077

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20042763

http://www.w3.org/2001/XMLSchema#string

P921

P932

4174270

http://www.w3.org/2001/XMLSchema#string